• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX SA VIDAS® D-DIMER EXCLUSION II ¿

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX SA VIDAS® D-DIMER EXCLUSION II ¿ Back to Search Results
Catalog Number 30455-02
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
On (b)(6) 2022, a customer in germany notified biomérieux of obtaining a possible too high value when using vidas® d-dimer exclusion ii 60t (ref.30455-02, lot number 1009306490, expiry date 21-mar-2023) with a patient sample.The customer reports that the patient, aged of 76 years old, has a too high d-dimer value: 1447.19 ng/ml.However, the physician does not believe this based on the patient's history.The patient is receiving a medication related to heart failure.There is no indication or report from the laboratory that the issue led to any adverse event related to the patient's state of health.A biomérieux internal investigation was opened.Note: reference 30455-02 is not sold or distributed in the united states.However, there is a similar device, u.S-only product reference, 30455-01.
 
Manufacturer Narrative
This report was initially submitted following notification from a customer in germany regarding a possible too high value when using vidas® d-dimer exclusion ii 60t (ref.30455-02, lot number 1009306490, expiry date 21-mar-2023) with a patient sample.A biomérieux internal investigation has been completed with the following results: investigation: 1.Device history record.The review did not highlight any issue during manufacturing for vidas® d-dimer exclusion ii 60t - 30455-02 lot 1009306490.There was no capa, no non conformity on vidas® d-dimer exclusion ii 60t - 30455-02 linked with customer¿s complaint.2.Complaint analysis: the complaint analysis did not reveal this issue as a systemic quality issue.3.Tests/analysis performed: products return: no material from customer available.Investigation protocol and obtained results: the tests were performed on internal samples available at complaints laboratory.Control charts analysis: the complaints laboratory analyzed the results: - of 4 internal samples targeted at 134, 585, 1277 and 1341 ng/ml - on 7 different lots including vidas® d-dimer exclusion ii 60t - 30455-02 lot 1009306490 mentioned by the customer.The analysis of the control charts showed that all results were within specifications.Customer¿s lot is in the trend of the other lots.Tests performed by complaints laboratory: - on internal samples - 4 internal samples targeted at 134, 585, 1277 and 1341 ng/ml were tested on vidas® d-dimer exclusion ii 60t - 30455-02 lot 1009306490 (retain kit).The results complied with the specifications without any significant difference compared to those observed before the lot release.Biomérieux did not observe any evolution over time of these samples activity.According to the package insert, chapter limitations of the method: ¿ ¿interference may be encountered with certain plasmas containing antibodies directed against reagent components.For this reason, assay results should be interpreted taking into consideration the patient's history (clinical probability).¿ 4.Root cause analysis and conclusion: the tests performed on the retain kit on vidas® d-dimer exclusion ii 60t - 30455-02 lot 1009306490 using internal samples.Unfortunately, the investigation did not manage to identify any obvious root cause.Without customer¿s return sample and kit, biomérieux cannot pursue investigation.The vidas d-dimer exclusion ii assay is indicated for use in conjunction with a clinical pre-test probability assessment model to exclude deep vein thrombosis (dvt) and pulmonary embolism (pe) disease in outpatients suspected of dvt or pe.According to the customer¿s feedback, the clinical context was not in favor of dvt or pe suspicion and the patient is elderly.In venous thromboembolism (vte) patients, the lysis of obstructing blood clots results in increased plasma d-dimer levels.However, d-dimer is not specific for vte and elevated levels are also observed in a variety of other clinical conditions where activation of coagulation and fibrinolysis occurs according to the above data, vidas® d-dimer exclusion ii - 30455-02 lot 1009306490 is within the expected performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® D-DIMER EXCLUSION II ¿
Type of Device
VIDAS® D-DIMER EXCLUSION II ¿
Manufacturer (Section D)
BIOMÉRIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR  69280
Manufacturer (Section G)
BIOMÉRIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR   69280
Manufacturer Contact
romain marti
5 rue des aqueducs
craponne 69290
FR   69290
MDR Report Key15536704
MDR Text Key301119872
Report Number8020790-2022-00101
Device Sequence Number1
Product Code DAP
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/21/2023
Device Catalogue Number30455-02
Device Lot Number1009306490
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/08/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-